Kheirollah Gholami

Kheirollah Gholami

Auto-generated profile, based on publicly available information

Kheirollah Gholami

Tehran University of Medical Sciences

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2018 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
ASAmir Sarayani
Amir Sarayani
MMMojgan Mashayekhi
Mojgan Mashayekhi
MNMarzieh Nosrati
Marzieh Nosrati
ZJZahra Jahangard-Rafsanjani
Zahra Jahangard-Rafsanjani
MJMohammadreza Javadi
Mohammadreza Javadi
KGKheirollah Gholami
Kheirollah Gholami

7 September 2007 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
MJMohammad Reza Javadi
Mohammad Reza Javadi
GSGloria Shalviri
Gloria Shalviri
KGKheirollah Gholami
Kheirollah Gholami
JSJamshid Salamzadeh
Jamshid Salamzadeh
GMGolshan Maghooli
Golshan Maghooli
SMSeid Mahdi Mirsaeedi
Seid Mahdi Mirsaeedi

9 February 2010 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
NMNiayesh Mohebbi
Niayesh Mohebbi
GSGloria Shalviri
Gloria Shalviri
MSMojtaba Salarifar
Mojtaba Salarifar
JSJamshid Salamzadeh
Jamshid Salamzadeh
KGKheirollah Gholami
Kheirollah Gholami

26 February 2022 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
BSBita Shahrami
Bita Shahrami
AFAida Sefidani Forough
Aida Sefidani Forough
FNFarhad Najmeddin
Farhad Najmeddin
EHElham Hadidi
Elham Hadidi
STSomayeh Toomaj
Somayeh Toomaj
KSKourosh Sadeghi
Kourosh Sadeghi

30 June 2017 in Pharmacy Practice
Verified
Journal Article
Open access
PDF file
ZJZahra Jahangard-Rafsanjani
Zahra Jahangard-Rafsanjani
NHNegar Hakimzadeh
Negar Hakimzadeh
ASAmir Sarayani
Amir Sarayani
SNSheyda Najafi
Sheyda Najafi
KHKazem Heidari
Kazem Heidari
KGKheirollah Gholami
Kheirollah Gholami
A community pharmacy-based cardiovascular risk screening service implemented in Iran

1 December 2014
Verified
Journal Article
Open access
TETaher Entezari-Maleki
Taher Entezari-Maleki
ATAzita Hajhossein Talasaz
Azita Hajhossein Talasaz
MSMojtaba Salarifar
Mojtaba Salarifar
MHMolouk Hadjibabaie
Molouk Hadjibabaie
MJMohammad Reza Javadi
Mohammad Reza Javadi
KGKheirollah Gholami
Kheirollah Gholami
Low plasma level of vitamin D is linked to the increased risk of cardiovascular diseases such as hypertension, diabetes, dyslipidemia and peripheral vascular diseases. Vitamin D deficiency is a worldwide problem that involves Iranian population. To the best of our knowledge, this was the first investigation on venous thromboembolism (VTE) subjects that assessed the correlation of vitamin D level with plasma P-selectin, hs-CRP, and risk factors of thrombosis. In this prospective pilot study, patients with diagnosis of acute deep vein thrombosis and/or pulmonary embolism were enrolled. All patients' clinical data, demographics and risk factors of thrombosis were evaluated. Plasma level of P-selectin and hs-CRP were measured by ELISA method. Radio immune assay method was used to determine plasma level of 25-hydroxy vitamin D (25(OH) D). In this study, 60 subjects were included. The mean +/- SD plasma 25-hydroxy vitamin D level (25(OH) D) of participants was 21.4 +/- 14.6 ng/mL. The vitamin D deficiency was detected in 60% of patients. No significant relation was found between the plasma 25(OH)D level and P-selectin and hs-CRP. In multiple regression analysis, there was a significant relationship between the level of 25(OH)D and the patients' age (beta = 0.452; p = 0.001), diabetes (beta = 0.280; p = 0.036) and positive family history of cardiovascular diseases (beta = 0.373; p = 0.003). Vitamin D deficiency is a frequent problem in Iranian VTE patients. Moreover, Plasma level of vitamin D is not associated with P-selectin and hs-CRP in VTE patients.